Robotically assisted cardiac surgery: minimally invasive techniques to totally endoscopic heart surgery

Area of Science:

• Minimally Invasive Cardiac Surgery
• Robotic-Assisted Surgery
• Congenital Heart Disease

Background:

• Technological advancements have driven progress in cardiac surgery towards less invasive approaches.
• Minimally invasive cardiac surgery has evolved from partial sternotomies to totally endoscopic robotic procedures.
• Robotic systems require Food and Drug Administration (FDA) approval and surgeon proficiency.

Purpose of the Study:

• To highlight advancements in robotic-assisted cardiac surgery.
• To discuss the application of robotics in congenital heart defect repair.
• To explore the future potential of robotic cardiac surgery.

Main Methods:

• Review of current robotic systems and their FDA approval process.
• Documentation of robotic use in coronary artery bypass grafting and valve procedures.
• Focus on recent developments in robotic closure of atrial septal defects.

Main Results:

• Robotic-assisted totally endoscopic atrial septal defect closure represents a significant advancement in congenital cardiac surgery.
• Robotic technology is well-established for coronary artery bypass grafting and select valve procedures.
• Current research is expanding robotic applications to congenital heart disease.

Conclusions:

• Robotic-assisted surgery offers a less invasive approach to complex cardiac procedures.
• Atrial septal defect closure using robotic assistance is a major step forward in pediatric cardiac surgery.
• Future robotic cardiac surgery aims to include more complex valve procedures and congenital defect repairs, with modifications for pediatric use.